This medical condition has either been superseded or has become inactive
| Specific Conditions |
|
| Level of Evidence | Insufficient data (Category 4a) |
|
Autoimmune neutropenia is a rare disorder caused by peripheral destruction of antibody-sensitised neutrophils by cells of the reticuloendothelial system. Intravenous immunoglobulin (IVIg) may be considered among treatment options in rare circumstances when the standard treatment of G-CSF fails. Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient. |
|
| Bibliography |
|---|
| Anderson, D, Ali, K, Blanchette, V, et al 2007, ‘Guidelines on the use of intravenous immune globulin for hematologic conditions’, Transfusion Medicine Reviews, vol. 21, no. 2, suppl. 1, pp. S9–56. |